Disease Areas
Diabetes
Obesity
Cardiovascular Disease (CVD)
Chronic Kidney Disease (CKD)
Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Neurodegenerative Diseases
Haemophilia
Sickle Cell Disease
Primary Hyperoxaluria
Growth Hormone Disorders
Hormone Replacement Therapy
Congresses
Scientific Publications
IME
Register
Login
My Account
Welcome to Novo Nordisk Science Hub
Are you a healthcare professional?
No
Yes
Congresses
European Society for Paediatric Endocrinology, 2024 (ESPE)
Response to daily and weekly recombinant human Growth Hormone (rhGH) treatment in children born small for gestational age is predicted more accurately by pre-treatment blood transcriptome than clinical variables
European Society for Paediatric Endocrinology, 2024 (ESPE)
:
{{ getPageNum(PDFPage) }}